Boston Scientific CEO Mike Mahoney says the company is closing the gap with its bigger competitors when it comes to emerging markets.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/17Eq4J9
Cap comentari:
Publica un comentari a l'entrada